未登录

T

Teresa Gil-Gil

Emory University

H指数:13

被引数:822

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Establishing communities of practice in undergraduate science classrooms

在本科科学课堂中建立实践社区

JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION

IF1.5

2026-01-010

PRE

The joint action of antibiotics; bacteriophage; and the innate immune response in the treatment of bacterial infections

抗生素、细菌噬菌体以及先天免疫反应在细菌感染治疗中的协同作用

Frontiers in Microbiology

IF4.5

2025-09-010

OA

The future of phage therapy in the USA

噬菌体疗法在美国的未来

Trends in Molecular Medicine

IF13.8

2025-04-220

OAAI

Antibiotic killing of drug-induced bacteriostatic cells

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2025-03-010

OAAI

The tradeoffs between persistence and mutation rates at sub-inhibitory antibiotic concentrations in Staphylococcus aureus

MICROBIOLOGY SPECTRUM

IF3.8

2025-03-010

OAAI

Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2024-12-270

PRE

The evolution of heteroresistance via small colony variants in Escherichia coli following long term exposure to bacteriostatic antibiotics

NATURE COMMUNICATIONS

IF15.7

2024-09-110

OAAI

Preserving the efficacy of antibiotics to tackle antibiotic resistance

MICROBIAL BIOTECHNOLOGY

IF5.2

2024-07-170

OA

Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-04-083

OAAI

Evolution of Resistance against Ciprofloxacin, Tobramycin, and Trimethoprim/Sulfamethoxazole in the Environmental Opportunistic Pathogen Stenotrophomonas maltophilia

ANTIBIOTICS-BASEL

IF4.6

2024-04-051

OAAI

In vivo genetic analysis of Pseudomonas aeruginosa carbon catabolic repression through the study of CrcZ pseudo-revertants shows that Crc-mediated metabolic robustness is needed for proficient bacterial virulence and antibiotic resistance

MICROBIOLOGY SPECTRUM

IF3.8

2023-12-123

OAAI

What's the Matter with MICs: Bacterial Nutrition, Limiting Resources, and Antibiotic Pharmacodynamics

MICROBIOLOGY SPECTRUM

IF3.8

2023-06-1513

OAAI

Translating eco-evolutionary biology into therapy to tackle antibiotic resistance

NATURE REVIEWS MICROBIOLOGY

IF103.3

2023-05-1926

PRE

Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2023-05-1811

PRE

Glucose-6-phosphate Reduces Fosfomycin Activity Against Stenotrophomonas maltophilia

葡萄糖-6-磷酸降低磷霉素对嗜麦芽窄食单胞菌的活性

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-05-102

OAAI

The Inactivation of Enzymes Belonging to the Central Carbon Metabolism Is a Novel Mechanism of Developing Antibiotic Resistance

IF4.6

2020-06-3022

OAAI

Naringenin Inhibition of the Pseudomonas aeruginosa Quorum Sensing Response Is Based on Its Time-Dependent Competition With N-(3-Oxo-dodecanoyl)-L-homoserine Lactone for LasR Binding

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2020-02-2853

OAAI

Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge

嗜麦芽窄食单胞菌的耐药性机制: 当前知识的回顾

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2020-02-21102

PREAI

Antimicrobial resistance: A multifaceted problem with multipronged solutions

MICROBIOLOGYOPEN

IF4.6

2019-11-1441

OAAI